BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gmitterová K, Minár M, Žigrai M, Košutzká Z, Kušnírová A, Valkovič P. Tacrolimus-induced parkinsonism in a patient after liver transplantation - case report. BMC Neurol 2018;18:44. [PMID: 29678162 DOI: 10.1186/s12883-018-1052-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ostroumova TM, Ostroumova OD, Soloveva AS. Drug-induced parkinsonism. RJTAO 2021;13:91-97. [DOI: 10.14412/2074-2711-2021-6-91-97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ostroumova TM, Ostroumova OD, Soloveva AS. Drugs associated with DIP. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-19-109-118] [Reference Citation Analysis]
3 Mulroy E, Baschieri F, Magrinelli F, Latorre A, Cortelli P, Bhatia KP. Movement Disorders and Liver Disease. Mov Disord Clin Pract 2021;8:828-42. [PMID: 34401403 DOI: 10.1002/mdc3.13238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Diaz-Segarra N, Edmond A, Yonclas P. Functional Improvement of Tacrolimus-Induced Parkinsonism With Amantadine After Liver Transplantation: A Case Report. Clin Neuropharmacol 2021;44:141-4. [PMID: 33871425 DOI: 10.1097/WNF.0000000000000444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Segura-aguilar J. Parkinson's disease. Clinical Studies and Therapies in Parkinson's Disease 2021. [DOI: 10.1016/b978-0-12-822120-4.00001-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Coe CL, Horst SN, Izzy MJ. Neurologic Toxicities Associated with Tumor Necrosis Factor Inhibitors and Calcineurin Inhibitors. Neurol Clin 2020;38:937-51. [PMID: 33040870 DOI: 10.1016/j.ncl.2020.07.009] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Verbeek TA, Stine JG, Saner FH, Bezinover D. Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group? Minerva Anestesiol 2020;86. [DOI: 10.23736/s0375-9393.20.14120-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 de Sousa Arantes Ferreira G, Conde Watanabe AL, de Carvalho Trevizoli N, Felippe Jorge FM, Ferreira Figueira AV, de Fatima Couto C, Viana de Lima L, Liduario Raupp DR. Tacrolimus-Associated Psychotic Disorder: A Report of 2 Cases. Transplant Proc 2020;52:1350-3. [PMID: 32197865 DOI: 10.1016/j.transproceed.2020.01.076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zhu YL, Guo XM, Qin ZB, Zhou ZJ, Cao J, Wu JM, Pu JL. Reversible Parkinsonism caused by Influenza B-associated encephalitis affecting bilateral basal ganglia: A case report. CNS Neurosci Ther 2020;26:396-8. [PMID: 31823469 DOI: 10.1111/cns.13278] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhang W, Egashira N, Masuda S. Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. Int J Mol Sci 2019;20:E3210. [PMID: 31261959 DOI: 10.3390/ijms20133210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
11 Walker C, Ray SD. Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs. Side Effects of Drugs Annual 2019. [DOI: 10.1016/bs.seda.2019.07.008] [Reference Citation Analysis]
12 . Tacrolimus. Reactions Weekly 2018;1703:249-249. [DOI: 10.1007/s40278-018-46623-x] [Reference Citation Analysis]